tadalafil has been researched along with Cognition Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuadrado-Tejedor, M; Franco, R; García-Barroso, C; García-Osta, A; Goicolea, MA; Lanciego, JL; Oyarzabal, J; Pascual-Lucas, M; Rico, AJ; Ricobaraza, A; Sallés, J; Unceta, N | 1 |
1 other study(ies) available for tadalafil and Cognition Disorders
| Article | Year |
|---|---|
Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Brain; Carbolines; Cognition Disorders; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; Half-Life; Humans; Macaca fascicularis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nootropic Agents; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Species Specificity; Sulfones; Tadalafil; Tissue Distribution | 2013 |